BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22267729)

  • 1. Curcumin prevents aggregation in α-synuclein by increasing reconfiguration rate.
    Ahmad B; Lapidus LJ
    J Biol Chem; 2012 Mar; 287(12):9193-9. PubMed ID: 22267729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity.
    Jha NN; Ghosh D; Das S; Anoop A; Jacob RS; Singh PK; Ayyagari N; Namboothiri IN; Maji SK
    Sci Rep; 2016 Jun; 6():28511. PubMed ID: 27338805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for preventing α-synuclein aggregation by a molecular tweezer.
    Acharya S; Safaie BM; Wongkongkathep P; Ivanova MI; Attar A; Klärner FG; Schrader T; Loo JA; Bitan G; Lapidus LJ
    J Biol Chem; 2014 Apr; 289(15):10727-10737. PubMed ID: 24567327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation of α-synuclein is kinetically controlled by intramolecular diffusion.
    Ahmad B; Chen Y; Lapidus LJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2336-41. PubMed ID: 22308332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson's disease.
    Gadad BS; Subramanya PK; Pullabhatla S; Shantharam IS; Rao KS
    Curr Pharm Des; 2012; 18(1):76-84. PubMed ID: 22211690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative.
    Gautam S; Karmakar S; Batra R; Sharma P; Pradhan P; Singh J; Kundu B; Chowdhury PK
    Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):589-603. PubMed ID: 28238838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization.
    Waxman EA; Mazzulli JR; Giasson BI
    Biochemistry; 2009 Oct; 48(40):9427-36. PubMed ID: 19722699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties.
    Ulrih NP; Barry CH; Fink AL
    Biochim Biophys Acta; 2008 Oct; 1782(10):581-5. PubMed ID: 18692132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein.
    Ahsan N; Mishra S; Jain MK; Surolia A; Gupta S
    Sci Rep; 2015 May; 5():9862. PubMed ID: 25985292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-cyclodextrin and curcumin, a potent cocktail for disaggregating and/or inhibiting amyloids: a case study with α-synuclein.
    Gautam S; Karmakar S; Bose A; Chowdhury PK
    Biochemistry; 2014 Jul; 53(25):4081-3. PubMed ID: 24933427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Interplay between Disordered and Ordered Oligomer Channels on the Aggregation Energy Landscapes of α-Synuclein.
    Chen X; Chen M; Wolynes PG
    J Phys Chem B; 2022 Jul; 126(28):5250-5261. PubMed ID: 35815598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-Pronged Interactions Underlie Inhibition of α-Synuclein Aggregation by β-Synuclein.
    Williams JK; Yang X; Atieh TB; Olson MP; Khare SD; Baum J
    J Mol Biol; 2018 Aug; 430(16):2360-2371. PubMed ID: 29782835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants of the aggregation behavior of alpha- and beta-synuclein.
    Rivers RC; Kumita JR; Tartaglia GG; Dedmon MM; Pawar A; Vendruscolo M; Dobson CM; Christodoulou J
    Protein Sci; 2008 May; 17(5):887-98. PubMed ID: 18436957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Mutations on the Reconfiguration Rate of α-Synuclein.
    Acharya S; Saha S; Ahmad B; Lapidus LJ
    J Phys Chem B; 2015 Dec; 119(50):15443-50. PubMed ID: 26572968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A KLVFFAE-Derived Peptide Probe for Detection of Alpha-Synuclein Fibrils.
    Wood A; Chau E; Yang Y; Kim JR
    Appl Biochem Biotechnol; 2020 Apr; 190(4):1411-1424. PubMed ID: 31776941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition effects of tanshinone on the aggregation of α-synuclein.
    Ji K; Zhao Y; Yu T; Wang Z; Gong H; Yang X; Liu Y; Huang K
    Food Funct; 2016 Jan; 7(1):409-16. PubMed ID: 26456030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein dynamics before aggregation.
    Srivastava KR; Lapidus LJ
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3572-3577. PubMed ID: 28320943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits aggregation of alpha-synuclein.
    Pandey N; Strider J; Nolan WC; Yan SX; Galvin JE
    Acta Neuropathol; 2008 Apr; 115(4):479-89. PubMed ID: 18189141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiphilic surface chemistry of fullerenols is necessary for inhibiting the amyloid aggregation of alpha-synuclein NACore.
    Sun Y; Kakinen A; Zhang C; Yang Y; Faridi A; Davis TP; Cao W; Ke PC; Ding F
    Nanoscale; 2019 Jun; 11(24):11933-11945. PubMed ID: 31188372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.